What to watch with CYP2D6 and Darmgesundheit?

CYP2D6 is primarily a drug-metabolizing enzyme, not a direct player in gut health. While some research hints at links between CYP2D6 variants and gut motility or microbiome composition via drug metabolism, the evidence is weak and mostly mechanistic. Consumer tests for 'gut health' (like the Magen-Darm-Gesundheit test mentioned in the context) typically do not include CYP2D6, and even if they did, the actionable insights for diet or probiotics would be negligible. The evidence grade is 'unclear/marketing' because no robust human studies connect CYP2D6 to clinically meaningful gut health outcomes. Do not use such tests to guide gut health decisions; focus on validated markers like stool calprotectin or microbiome diversity (with caution).